nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—Striated Muscle Contraction—TPM2—esophageal cancer	0.0988	0.109	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM2—esophageal cancer	0.0839	0.0922	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM4—esophageal cancer	0.0749	0.0823	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TPM2—esophageal cancer	0.0663	0.0729	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM1—esophageal cancer	0.0637	0.0699	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM4—esophageal cancer	0.0636	0.0699	CbGpPWpGaD
Levosimendan—TNNC1—Striated Muscle Contraction—TPM1—esophageal cancer	0.0541	0.0594	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TPM4—esophageal cancer	0.0503	0.0552	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—TPM1—esophageal cancer	0.0427	0.047	CbGpPWpGaD
Levosimendan—KCNJ8—Inwardly rectifying K+ channels—GNG7—esophageal cancer	0.0326	0.0359	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.016	0.0176	CbGpPWpGaD
Levosimendan—KCNJ11—Inwardly rectifying K+ channels—GNG7—esophageal cancer	0.0155	0.017	CbGpPWpGaD
Levosimendan—KCNJ8—Potassium Channels—GNG7—esophageal cancer	0.0129	0.0142	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.0129	0.0141	CbGpPWpGaD
Levosimendan—KCNJ8—bronchus—esophageal cancer	0.0121	0.135	CbGeAlD
Levosimendan—KCNJ8—smooth muscle tissue—esophageal cancer	0.0118	0.132	CbGeAlD
Levosimendan—KCNJ8—trachea—esophageal cancer	0.0109	0.121	CbGeAlD
Levosimendan—TNNC1—lung—esophageal cancer	0.0104	0.116	CbGeAlD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0103	0.0113	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—ADCYAP1—esophageal cancer	0.0103	0.0113	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00951	0.0104	CbGpPWpGaD
Levosimendan—PDE3A—smooth muscle tissue—esophageal cancer	0.00946	0.105	CbGeAlD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—esophageal cancer	0.00931	0.0102	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00918	0.0101	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—GNG7—esophageal cancer	0.00833	0.00915	CbGpPWpGaD
Levosimendan—KCNJ8—lung—esophageal cancer	0.00781	0.087	CbGeAlD
Levosimendan—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS3—esophageal cancer	0.00748	0.00822	CbGpPWpGaD
Levosimendan—KCNJ11—Regulation of insulin secretion—GNG7—esophageal cancer	0.00746	0.0082	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00714	0.00784	CbGpPWpGaD
Levosimendan—TNNC1—lymph node—esophageal cancer	0.00712	0.0793	CbGeAlD
Levosimendan—PDE3A—lung—esophageal cancer	0.00624	0.0694	CbGeAlD
Levosimendan—KCNJ11—Potassium Channels—GNG7—esophageal cancer	0.0061	0.00671	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—PDE4D—esophageal cancer	0.00604	0.00664	CbGpPWpGaD
Levosimendan—KCNJ11—Integration of energy metabolism—GNG7—esophageal cancer	0.00587	0.00645	CbGpPWpGaD
Levosimendan—PDE3A—G alpha (s) signalling events—GNG7—esophageal cancer	0.00575	0.00632	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—GNG7—esophageal cancer	0.00563	0.00618	CbGpPWpGaD
Levosimendan—KCNJ8—lymph node—esophageal cancer	0.00534	0.0595	CbGeAlD
Levosimendan—KCNJ8—Neuronal System—ALDH2—esophageal cancer	0.00527	0.00579	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAPZA1—esophageal cancer	0.00473	0.00519	CbGpPWpGaD
Levosimendan—KCNJ11—lymph node—esophageal cancer	0.00435	0.0485	CbGeAlD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00429	0.00471	CbGpPWpGaD
Levosimendan—PDE3A—lymph node—esophageal cancer	0.00427	0.0475	CbGeAlD
Levosimendan—PDE3A—Platelet homeostasis—NOS2—esophageal cancer	0.00363	0.00398	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.0035	0.00385	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ATP1B2—esophageal cancer	0.00313	0.00344	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—NOS3—esophageal cancer	0.00292	0.0032	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—DOCK2—esophageal cancer	0.00283	0.00311	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—GNG7—esophageal cancer	0.00267	0.00293	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—ALDH2—esophageal cancer	0.0025	0.00274	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PFN1—esophageal cancer	0.00244	0.00268	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00239	0.00262	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.0021	0.00231	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CFL1—esophageal cancer	0.00198	0.00218	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00191	0.0021	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—GNG7—esophageal cancer	0.00187	0.00205	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GDI2—esophageal cancer	0.00175	0.00192	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HSPA5—esophageal cancer	0.00152	0.00167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC52A3—esophageal cancer	0.00141	0.00155	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BLVRB—esophageal cancer	0.00141	0.00155	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKAP13—esophageal cancer	0.00136	0.00149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KMT2D—esophageal cancer	0.00127	0.00139	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PDE4D—esophageal cancer	0.00124	0.00136	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKAP13—esophageal cancer	0.00123	0.00135	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA1—esophageal cancer	0.0012	0.00132	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC10A2—esophageal cancer	0.0012	0.00132	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNG7—esophageal cancer	0.00118	0.0013	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADCYAP1—esophageal cancer	0.00113	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ABL1—esophageal cancer	0.00113	0.00124	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PDE4D—esophageal cancer	0.00113	0.00124	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA2—esophageal cancer	0.00109	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNG7—esophageal cancer	0.00107	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL2—esophageal cancer	0.00104	0.00114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WWOX—esophageal cancer	0.00103	0.00113	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADH7—esophageal cancer	0.00102	0.00112	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCE1—esophageal cancer	0.00102	0.00112	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FKBP1A—esophageal cancer	0.000982	0.00108	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000966	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WIF1—esophageal cancer	0.00096	0.00105	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL2—esophageal cancer	0.000944	0.00104	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—SST—esophageal cancer	0.00094	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GHRL—esophageal cancer	0.000916	0.00101	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ADH1B—esophageal cancer	0.000893	0.000981	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000886	0.000973	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ANXA1—esophageal cancer	0.000877	0.000964	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—SST—esophageal cancer	0.000853	0.000938	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMP—esophageal cancer	0.000853	0.000937	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GHRL—esophageal cancer	0.000832	0.000914	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP26A1—esophageal cancer	0.00083	0.000912	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PFN1—esophageal cancer	0.000828	0.00091	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—esophageal cancer	0.000812	0.000893	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALOX15—esophageal cancer	0.000809	0.000888	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTO1—esophageal cancer	0.000771	0.000848	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TPI1—esophageal cancer	0.000771	0.000848	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ELMO1—esophageal cancer	0.000744	0.000818	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOB—esophageal cancer	0.00074	0.000813	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CREBBP—esophageal cancer	0.000729	0.000801	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKAP13—esophageal cancer	0.000727	0.000799	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GAPDH—esophageal cancer	0.000712	0.000782	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CRABP1—esophageal cancer	0.000706	0.000775	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000671	0.000737	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNG7—esophageal cancer	0.000671	0.000737	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4D—esophageal cancer	0.000665	0.000731	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—esophageal cancer	0.000653	0.000718	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNG7—esophageal cancer	0.000633	0.000695	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDH2—esophageal cancer	0.000629	0.000691	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—esophageal cancer	0.000598	0.000657	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—XIAP—esophageal cancer	0.000593	0.000651	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2A6—esophageal cancer	0.000591	0.00065	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNA1—esophageal cancer	0.000561	0.000616	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—esophageal cancer	0.000561	0.000616	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS1—esophageal cancer	0.000561	0.000616	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL2—esophageal cancer	0.000557	0.000612	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSME2—esophageal cancer	0.000552	0.000607	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSME1—esophageal cancer	0.000552	0.000607	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSME1—esophageal cancer	0.000521	0.000572	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSME2—esophageal cancer	0.000521	0.000572	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ANXA1—esophageal cancer	0.000518	0.000569	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SST—esophageal cancer	0.000504	0.000554	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EP300—esophageal cancer	0.000497	0.000546	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GHRL—esophageal cancer	0.000491	0.00054	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH3—esophageal cancer	0.000491	0.00054	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FBXW7—esophageal cancer	0.000483	0.000531	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1B1—esophageal cancer	0.000477	0.000524	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP19A1—esophageal cancer	0.000448	0.000492	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH2—esophageal cancer	0.000441	0.000484	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—esophageal cancer	0.000409	0.000449	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—esophageal cancer	0.000392	0.000431	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR2—esophageal cancer	0.000391	0.000429	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMAD4—esophageal cancer	0.00037	0.000407	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—esophageal cancer	0.000368	0.000404	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—esophageal cancer	0.000356	0.000391	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—esophageal cancer	0.000303	0.000333	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—esophageal cancer	0.00029	0.000318	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—esophageal cancer	0.000273	0.0003	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CREBBP—esophageal cancer	0.000262	0.000288	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREBBP—esophageal cancer	0.000247	0.000272	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—esophageal cancer	0.000243	0.000267	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—esophageal cancer	0.000235	0.000258	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000232	0.000255	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—esophageal cancer	0.000221	0.000243	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—esophageal cancer	0.000215	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000211	0.000232	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—esophageal cancer	0.000207	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—esophageal cancer	0.000183	0.000201	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—EP300—esophageal cancer	0.000179	0.000196	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—esophageal cancer	0.000177	0.000194	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EP300—esophageal cancer	0.000168	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—esophageal cancer	0.000147	0.000161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—esophageal cancer	0.000144	0.000158	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—esophageal cancer	0.000132	0.000145	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—esophageal cancer	0.000125	0.000137	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—esophageal cancer	0.000121	0.000132	CbGpPWpGaD
